facebook linkedin twitter

Lawmakers Lay Blame for Opioid Epidemic on Purdue Pharma

December 18, 2020 by Tom Ramstack
In this image from House Television, David Sackler, a member of the family that owns Purdue Pharma testifies via video to a House Oversight Committee hearing Thursday, Dec. 17, 2020. Members of the family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid crisis but have stopped short of apologizing or admitting wrongdoing. (House Television via AP)

WASHINGTON — Members of Congress lashed into the Sackler family Thursday for its pharmaceutical company’s role in promoting a painkiller blamed for killing about 230,000 Americans.

Lawmakers on the House Oversight and Reform Committee said the Sacklers and Purdue Pharma L.P. enriched themselves despite knowing about the risks and addictiveness of their opioid OxyContin.

“Watching you testify makes my blood boil,” Rep. James Cooper, D-Tenn., told David Sackler, a former Purdue Pharma board member. 

The lawmakers accused Purdue Pharma of concealing the dangers of OxyContin while earning as much as $30 billion from the drug since sales started in 1996.

Common side effects of opioids include euphoria but also addiction, hallucinations and respiratory depression, sometimes leading to death.

The Centers for Disease Control reports opioids have killed about 450,000 Americans. An estimated 230,000 died from complications from prescriptions of OxyContin, the CDC says.

Purdue Pharma is a privately-held pharmaceutical company founded and principally owned by members of the Sackler family, one of the 15 wealthiest families in the United States. The family members left the board of directors in 2018.

In 2007, the company paid $634 million as one of the largest fines ever levied against a pharmaceutical firm for mislabeling a product. Three of its executives were found guilty of criminal charges.

The company shifted its focus to medicines designed to prevent addiction but continued to market and sell opioids as late as 2019.

Purdue Pharma filed for Chapter 11 bankruptcy protection on September 15, 2019. On October 21, 2020, the Stamford, Conn.-based company reached a settlement agreement with the Justice Department worth $8.3 billion.

As part of the agreement, company officials admitted Purdue Pharma “knowingly and intentionally conspired and agreed with others to aid and abet” doctors dispensing medication “without a legitimate medical purpose.”

Members of the Sackler family will pay an additional $225 million out of their personal fortunes. Purdue Pharma is dissolving as a company.

Two Sackler family members who sat on the board of directors of Purdue Pharma testified they had no intention of hurting anyone when they developed the drug designed to help manage sometimes disabling pain. They also said they acted within Food and Drug Administration regulations.

OxyContin “has helped and it continues to help millions of Americans,” David Sackler said.

He apologized for the harm the drug has caused but added, “I believe I conducted myself properly and ethically” with his company and family financial dealings.

Kathe Sackler, a former Purdue Pharma vice president, called the addictions and deaths from OxyContin “extremely distressing.”

She added that the company followed standard procedures for drug development, approval and sales.

“There’s nothing I could find that I would do differently,” Kathe Sackler said.

The hearing started with a three-minute film that showed relatives or victims of overdoses telling about their personal tragedies from OxyContin.

One man told about his 18-year-old daughter taking a prescription dose of the drug before it induced respiratory failure.

“She only took one pill,” he said. “She went to sleep on the couch and she never woke up.”

A professional woman who worked in the museum industry talked about her unintended overdose from an OxyContin prescription in 2017 followed by months in a rehab clinic.

“My addiction destroyed my relationships with my friends and family and almost destroyed my career of 50 years,” she said.

Several lawmakers said or implied the Justice Department should consider additional criminal charges against the Sacklers.

They said the Sackler family withdrew more than $10 billion from the company’s assets, particularly as lawsuits filed by states and individuals made it clear Purdue Pharma was about to suffer a big financial penalty.

“They wanted to get out as much money as possible,” said Rep. Carolyn Maloney, D-N.Y., who chairs the Oversight and Reform Committee.

Despite denials from David Sackler, Maloney said, “I think you did know that more judgments and settlements were coming.”

Rep. James Comer, R-Ky., who co-chairs the committee, told the Sacklers, “We don’t agree on a lot on this committee in a bipartisan way. But I think our opinion of Purdue Pharma and the actions of your family, we all agree are sickening.”

Prescription Drugs

Merck Says Experimental Pill Cuts Worst Effects of COVID-19

WASHINGTON (AP) — Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people... Read More

WASHINGTON (AP) — Drugmaker Merck said Friday that its experimental COVID-19 pill reduced hospitalizations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the U.S. and around the world to authorize its use. If cleared,... Read More

September 14, 2021
by Dan McCue
Moderates Seek Changes to Drug Pricing Proposal

A group of moderate Democrats led by Rep. Scott Peters sought on Tuesday to change the House debate on how... Read More

A group of moderate Democrats led by Rep. Scott Peters sought on Tuesday to change the House debate on how prescription drug prices are set in the U.S., arguing sweeping proposals put forward by progressives could threaten passage of the $3.5 trillion budget bill. The push... Read More

September 9, 2021
by Dan McCue
White House Unveils Plan to Cut Prescription-Drug Prices

WASHINGTON -- The Biden administration on Thursday offered the first detailed look at actions the White House may take in... Read More

WASHINGTON -- The Biden administration on Thursday offered the first detailed look at actions the White House may take in conjunction with congressional action to lower prescription drug prices. The 29-page plan, released through the Department of Health and Human Services, backs the intention of many... Read More

September 1, 2021
by Dan McCue
Kansas Health Officials Urging Residents Not to Take Livestock Drug for COVID

TOPEKA, Kan. - A drug most commonly given to horses and cows as an anti-parasite medicine should not be taken... Read More

TOPEKA, Kan. - A drug most commonly given to horses and cows as an anti-parasite medicine should not be taken by humans to treat or prevent COVID-19, the Kansas Department of Health and Environment said in a Wednesday advisory. Ivermectin was introduced as a veterinary drug... Read More

Judge Set to Rule on Purdue Pharma's Opioid Settlement Plan

A federal bankruptcy judge is expected to rule Wednesday on whether to accept a settlement between OxyContin maker Purdue Pharma,... Read More

A federal bankruptcy judge is expected to rule Wednesday on whether to accept a settlement between OxyContin maker Purdue Pharma, the states and thousands of local governments over an opioid crisis that has killed a half-million Americans over the last two decades. If Judge Robert Drain... Read More

August 23, 2021
by Dan McCue
Poll: NJ Voters Want a Fiscally Responsible Congress to Tackle True Health Care Concerns

Voters in New Jersey’s 5th Congressional District, a traditional swing or battleground district nestled against the southeast portion of New... Read More

Voters in New Jersey’s 5th Congressional District, a traditional swing or battleground district nestled against the southeast portion of New York State, are united in many key respects when it comes to spending and health care reforms, a recent survey found. Strong majorities want to see... Read More

News From The Well
scroll top